SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Cipla acquires rights to market skin care products of Percos India: Report

03 Sep 2015 Evaluate

Cipla, one of India’s leading generic pharmaceutical companies has reportedly acquired the exclusive rights to market skin care products of Percos India. This deal may be worth an estimated Rs 90 crore. The company will market few fast growing brands like Vedaderm, Claz, Actipeel, Tryses and Glycoveda, which have collective sales of around Rs 10 crore.

Cipla is a global pharmaceutical company which uses cutting edge technology and innovation to meet the everyday needs of all patients. For more than 70 years, Cipla has emerged as one of the most respected pharmaceutical names in India as well as across more than 150 countries. The company’s portfolio includes over 1500 products across wide range of therapeutic categories with one quality standard globally.

Cipla Share Price

1233.60 -4.70 (-0.38%)
20-Apr-2026 09:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1673.75
Dr. Reddys Lab 1235.00
Cipla 1233.60
Zydus Lifesciences 937.25
Lupin 2328.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×